ERDOG, A. Et Al. 2013. In Vitro Characterization of a Liposomal Formulation of Celecoxib Containing 1,2-Distearoyl-sn-Glycero-3-Phosphocholine, Cholesterol, and Polyethylene Glycol and its Functional Effects Against Colorectal Cancer Cell Lines. JOURNAL OF PHARMACEUTICAL SCIENCES , vol.102, no.10 , 3666-3677.

ERDOG, A., Limasale, Y. D. P., KESKİN, D., TEZCANER, A., & BANERJEE, S., (2013). In Vitro Characterization of a Liposomal Formulation of Celecoxib Containing 1,2-Distearoyl-sn-Glycero-3-Phosphocholine, Cholesterol, and Polyethylene Glycol and its Functional Effects Against Colorectal Cancer Cell Lines. JOURNAL OF PHARMACEUTICAL SCIENCES , vol.102, no.10, 3666-3677.

ERDOG, Asli Et Al. "In Vitro Characterization of a Liposomal Formulation of Celecoxib Containing 1,2-Distearoyl-sn-Glycero-3-Phosphocholine, Cholesterol, and Polyethylene Glycol and its Functional Effects Against Colorectal Cancer Cell Lines," JOURNAL OF PHARMACEUTICAL SCIENCES , vol.102, no.10, 3666-3677, 2013

ERDOG, Asli Et Al. "In Vitro Characterization of a Liposomal Formulation of Celecoxib Containing 1,2-Distearoyl-sn-Glycero-3-Phosphocholine, Cholesterol, and Polyethylene Glycol and its Functional Effects Against Colorectal Cancer Cell Lines." JOURNAL OF PHARMACEUTICAL SCIENCES , vol.102, no.10, pp.3666-3677, 2013

ERDOG, A. Et Al. (2013) . "In Vitro Characterization of a Liposomal Formulation of Celecoxib Containing 1,2-Distearoyl-sn-Glycero-3-Phosphocholine, Cholesterol, and Polyethylene Glycol and its Functional Effects Against Colorectal Cancer Cell Lines." JOURNAL OF PHARMACEUTICAL SCIENCES , vol.102, no.10, pp.3666-3677.

@article{article, author={Asli ERDOG Et Al. }, title={In Vitro Characterization of a Liposomal Formulation of Celecoxib Containing 1,2-Distearoyl-sn-Glycero-3-Phosphocholine, Cholesterol, and Polyethylene Glycol and its Functional Effects Against Colorectal Cancer Cell Lines}, journal={JOURNAL OF PHARMACEUTICAL SCIENCES}, year=2013, pages={3666-3677} }